Betz Stephen F.

CIK 00018865751 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001886575

Recent Transactions

50 trades

Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2026-03-16$37.11/sh−6,371→ 141,342 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2026-03-16$37.77/sh−4,241→ 137,101 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2026-02-23+30,000→ 147,713 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2026-02-23+47,000→ 47,000 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-12-26$1.91/sh+18,000→ 117,713 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2025-12-26−18,000→ 90,514 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-06-12$1.91/sh+71,525→ 180,551 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2025-06-12−16,645→ 58,198 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2025-06-12−71,525→ 108,514 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-06-12$32.23/sh−97,483→ 99,713 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-06-12$9.28/sh+16,645→ 197,196 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-03-19$34.83/sh−291→ 108,588 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-03-19$34.17/sh−5,479→ 108,879 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-02-20+43,000→ 114,358 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2025-02-20+65,000→ 65,000 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-12-16$1.91/sh+2,331→ 71,358 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2024-12-16−2,331→ 180,039 total
Other
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-11-20$14.98/sh+451→ 71,358 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-09-10$51.50/sh−1,035→ 68,576 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-08-26$53.19/sh−3,000→ 69,611 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-08-12$47.68/sh−3,000→ 72,611 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-07-25$53.43/sh−3,000→ 75,611 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-07-10$48.55/sh−3,000→ 78,611 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-06-25$45.37/sh−3,000→ 80,643 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-06-10$43.86/sh−3,000→ 83,643 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-05-28$47.49/sh−3,000→ 86,643 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-05-10$49.43/sh−3,000→ 89,643 total
Tax Payment
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-03-18$38.14/sh−3,655→ 92,643 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-03-04+23,000→ 96,298 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2024-03-04+87,000→ 87,000 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-01-25$37.26/sh−3,000→ 73,298 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-01-10$37.65/sh−3,000→ 76,298 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-12-26$35.89/sh−3,000→ 79,298 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-12-11$32.87/sh−3,000→ 82,298 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-11-27$31.84/sh−3,000→ 85,298 total
Tax Payment
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-03-16$17.12/sh−1,410→ 86,879 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2023-03-01+110,000→ 110,000 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-03-01+23,600→ 88,289 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-02-01$19.59/sh−3,126→ 64,689 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-01-25$21.07/sh−8,336→ 67,815 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-01-17$18.00/sh−3,126→ 76,151 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-01-03$18.35/sh−3,126→ 79,277 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2022-12-15$16.00/sh−3,126→ 82,403 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2022-12-01$17.84/sh−3,126→ 84,968 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2022-11-15$18.72/sh−3,126→ 88,094 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2022-11-01$18.52/sh−3,126→ 91,220 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2022-10-17$17.73/sh−3,126→ 94,346 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2022-10-03$19.64/sh−3,126→ 97,472 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2022-09-15$21.01/sh−4,168→ 100,598 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2022-09-07$21.00/sh−1,042→ 104,766 total

Companies

Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
$CRNX

Recent Filings

Address

C/O CRINETICS PHARMACEUTICALS, INC. 6055 LUSK BOULEVARD

SAN DIEGO, CA, 92121

View on SEC.gov